Humans tend to produce far less growth hormone as they get older, losing as much as 14% of circulating GH in their body every 10 years after the age of 30: This contributes to many of the various and common aging effects, such as decreased energy, increased difficulty in maintaining or building muscle, a slowing metabolism, slowed or less effective injury or wound healing, and more. Therefore, Ipamorelin allows us to bypass this natural aging process by allowing our body to produce growth hormone as if it was in its absolute prime
Considering that some of the GLP-1R agonists also decrease body weight, these have received approval for the treatment of obesity in humans [for a review, see Following ingestion of a meal, the GLP-1 levels rapidly increase
IVM has a variety of different mechanisms of action in different cancers, and its potential for synergistic effects and enhanced efficacy in combination therapy was of particular interest to us
Our experienced physicians determine if TRT is appropriate based on symptoms, physical exam, medical history, and lab testing
Contact (772) 971-5867 today to schedule your consultation
Table of Contents: What is PT-141, and how does it work
